Dr. Sarah Marzi: How Epigenetics & Toxins Drive Neurodegenerative Disease

Epigenetics & Neurodegenerative Disease

• 💡 Complex diseases like Alzheimer's and Parkinson's are rarely caused by a single gene but by a combination of many genetic risk factors interacting with environmental exposures and lifestyle.
• 🧠 Epigenetics is the study of how genes are turned on and off, acting as biochemical switches that regulate gene expression, which can be influenced by these factors.
• 🎯 Understanding these upstream regulatory factors and cellular processes can lead to therapeutic targets that reverse or prevent disease changes.

Microglia's Central Role in Alzheimer's

• 🔑 Genetic risk for Alzheimer's disease is overwhelmingly concentrated in regulatory regions of the genome active specifically in microglia, the brain's immune cells.
• 🔬 Microglia are critical for clearing protein clumps (like amyloid beta) and can become pro-inflammatory, contributing to neuronal vulnerability and degeneration.
• ⚠️ In Alzheimer's, microglia can exhibit a loss of protective functions (e.g., impaired phagocytosis) and a gain of harmful functions (e.g., producing pro-inflammatory cytokines).

APOE Genotypes and Vitamin D Connection

• 🧬 APOE genotypes fundamentally reprogram microglial states, with APOE4 driving a pro-inflammatory, less protective response and impaired protein clearance and motility.
• ✅ Conversely, APOE2 is a strong protective factor, associated with anti-inflammatory microglial responses and enhanced protective functions.
• ☀️ The Vitamin D Receptor (VDR) signaling is significantly enhanced in protective APOE2 microglia, driving anti-inflammatory gene expression programs, linking vitamin D deficiency to Alzheimer's risk.

Environmental Toxins and Parkinson's Risk

• 🌳 Parkinson's disease has a strong environmental component, with specific exposures like pesticides playing a significant role in increasing risk.
• 📝 Environmental toxins, such as Rotenone, can leave an "epigenetic memory" in cells, gradually changing gene regulation over decades and leading to harmful gene expression programs.
• 🔬 In Parkinson's, Rotenone exposure in rat models shows mitochondrial dysfunction and unique immune upregulation (including C1Q activation) specifically in the substantia nigra, contributing to neuronal death and synaptic pruning.

Histones, Oligodendrocytes, and Future Therapies

• 🔍 Widespread changes in histone modifications (which control how tightly DNA is wrapped and genes are expressed) are observed in Alzheimer's brains, particularly in the entorhinal cortex.
• 🧠 Beyond microglia, oligodendrocytes (the brain's insulating cells) also show surprisingly vast epigenetic changes in Alzheimer's, indicating their underappreciated role in disease.
• 🚀 Future therapies may require a cocktail approach targeting multiple cellular processes and upstream regulatory factors, rather than single-target drugs, to effectively treat complex neurodegenerative diseases.
• 📈 Machine learning and advanced biomarker analysis (e.g., cell-free DNA methylation) hold promise for earlier and more precise detection of neurodegenerative diseases in peripheral samples.